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some authors consider it unnecessary to treat these lesions. 3 Overdiagnosis on the basis of cytologic diagnosis is a growing problem. <5 Referral for colposcopically directed biopsy is certainly justifiable in patients with smears read as severe dysplasia because the majority a will indeed prove to have high-grade lesions. The most frequent cytologic screening abnormality is mild or moderate dysplasia, and here the prevalence of high-grade squamous intraepithelial lesions is about 50%.6' • In The Netherlands it is recommended to restrict colposcopy only to those patients with two consecutive mildly or moderately dysplastic smears.
Because of the limited value of mildly or moderately dysplastic smears in predicting histologic high-grade squamous intraepithelial lesions, it could be useful to Volume 177, Nmnber 3
[3ol~eF1 et ak 549 Am J Obstet Gynecol develop a secondm T triage that would identify those patients most iikely to have high-grade lesions before colposcopy, as was suggested by Reid and Lorincz. s A similar challenge is encountered in patients with smears read as atypical squamous cells of undetermined significance according to the Bethesda classification, in whom the rate of high-grade lesions after colposcopy is eren lower. 9 Because the incidence of atypical squamous cells of undetermined significance is increasing in the United States, a secondary triage has been recommended for these patients as well. 9 Several studies have examined the role of tests for human papillomavirus (HPV) in screening for cervical cancer.6,7.9.~0 The rate of HPV detection has been shown to vary, depending on which test is used. ~~ HPV deoxyribonuc]eic acid (DNA) can be detected in 81% of abnormal cep«ical smears by use of a test based on the amplification of DNA (polymerase chain reacdon) but in only 60% of abnormal smears if a nonamplification test such as hybrid capture is performed. ~~
The prediction of high-grade squamous in~raepithelial lesions has been studied with different HPV tests, 7'~° whereas the prediction of low-grade lesions has been investigated only with the hybrid capture test. % 9 Cox et al. 9 concluded that there is a role for HPV testing by hybrid capture in selecting paUents with a~]oical squamous cells of undetermined significance for colposcopy. 9 They reported that 14 of 15 patients with, high-grade lesions were HPV positive and 90 of 125 patients with low-grade lesions were HPV negative by the hybrid capture test. With use of the hybrid capture method to test 96 paüents with cytologic low-grade dysplasia for the presence of HPV, Hatch et al. "~ found histotogic highgrade lesions in 37 patients, of whom 29 were HPV positive. These authors recommended against the use of hybrid capmre HPV tesdng as a triage method for patients with mildly or moderately dysplastic smears because patients with a high-grade lesion were missed.
The alm of the current study was to determine whether HPV testing by polymerase chain reacüon could discriminate between the presence and absence of high-grade squamous intraepithelial lesions in patients with cytologically mild or moderate dysplasia. The results of two polymerase chain reacuons were compared to ascertain which one would be most effective in predicüng the absence of high-grade lesions and thereby possibly minimizing unnecessaß colposcopic examination.
Material and methods
Study population. The study population included consecutive patients referred for colposcopy to the outpatient clinic of the Academic Medical Center in Amsterdato or to the De Heel Hospital in Zaandam. The included patients had a single or repeated mildly or moderately dysplastic smear, PAP IIIA as classified according to the Papanicolaou system, which is used in the Netherlands. Patients with a history of colposcopy or previous treatment of dysplasia were not included.
After informed consent was obtained from the patients, cervical smears for HPV DNA detection were taken with a cotton swab and placed in 1 ml of Virapap transportation medium in Virapap collection tubes (Digene Diagnostics). They were kept at +4 ° C for shortterm storage and at -20 ° C for long-term storage according to the specifications of the Virapap determination protocol.
Colposcopy was performed after application of 3% acetic acid. Punch biopsies were taken from the most abnormal area of the celwix. An endoce~wical curettage was performed if the transformation zone was not entirely visible. The material was fixed in formaldehyde, The colposcopists were unaware of the HPV diagnosis at: the time of examination.
HPV DNA analysis. For DNA purification 100 b~l of Virapap transportation medium containing scraped cervital cells was taken. DNA_ was extracted once with phenol-chloroform and precipitated with etha~ol. Finally, the precipitated DNA was dissolved in 100 b~l of 10 mmol/L Tris-hydrochloric acid and 1 mmol/L ethvlenediaminetetraacetic acid (pH 7.0) and stored at -20 ° C until use.
Detection of HPV DNA by polymerase chain reaction amplification was performed with the degenerated consensus primer pair CPI and CPII. which amplifies a 188 bp fragment in the E1 open reading frame of a broad spectrum of genital HPV ~pes. The polymerase chain reaction wirb the primer pair CPI/IIG was performed as described before. 11'w-The 100 Ixt polymerase chain reaction mixture consisted of 10 mmol/L Tris-hvdrochloric acid (pH 8.8), 50 mmol/L potassium chloride, 3.6 mmol/L magnesium chloride , 0.1 mg of bovine sermn albumin per bd, 0.2 mmol/L of each deoxynucleoside triphosphate, 150 ng of each pnmer. 1.5 U of Taq polymerase (Amplitaq). and 10 Ixl of the DNA sample. Forty-step cycles (1 minute at 94 ° C, 1 minute at ä5 ° C. and 2 minutes at 72 ° C} were perIbrmed and the ampIification product was analyzed on a 2% ethidium bromidestained agarose gel after phenol-chloroform extraction and ethanol precipitation Taq polymerase (Amplitaq). Forty-step cycles (1 minute at 94 ° C, 2 minutes at 55 ° C, and 3 minutes at 72 o C) were performed. Amplimers were detected exactly as described by the manufacturer. A 5 Ixl sample of polymerase chain reaction mixture was denatured in base and hybridized to two different sets of unlabeled ribonucleic acid probes. Set A contained probes for the nononcogenic HPV types 6, 11, 42, 43, and 44 and set B contained probes for the oncogenic HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, and 58. The hybridization mixture was transferred to a streptavidin-coated microplate on which the ribonucleic acid-DNA hybrids were captured. These hybrids were subsequently detected by an alkaline phosphatase-labeled antibody directed against ribonucleic acid-DNA hybrids. Colorimetric measurements were obtained with use of para-nitrophenylphenol as a substrate in a microtiter reader. Appropriate negative and positive controls were included as prescribed by the manufactutet.
To determine whether samples were adequate for HPV detection by polymerase chain reaction amplification, Vd of the DNA sample. Forty-step cycles (1 minute at 94 ° C, 1 minute at 55 ° C, and 2 minutes at 72 ° C) were performed and then 10 Ixl of the amplification product was analyzed on a 2% ethidium bromide-stained agarose gel. All samples were positive with this polymerase chain reaction. Between patient samples negative controls (water only) were used throughout the extraction procedure. The polymerase chain reaction results of these samples remained negative.
The HPV types of the CPI/IIG polymerase chain reaction-positive samples were determined by direct sequence analysis of the purified 188 bp product with use of the 3' primer (CPI) as a sequencing primer. 1~ Polymerase chain reaction products were concentrated and purified before sequence analysis by phenol-chloroform extraction, ethanol precipitation, and agarose gel electrophoresis. The appropriate bands were extracted from the agarose gel according to a modification of the procedure described by Boom et al. 14 The HPV detection and the sequence analysis were perforrned without prior knowledge of clinical data.
Histologic study. The cervical biopsy specimens were diagnosed according to the Bethesda classification systern 15 as the absence of dysplasia, low-, or high-grade squamous intraepithelial lesions by a single pathologist who had no prior knowledge of the patients' clinical data and HPV status. Low-grade lesions were defined as mild cellular and nuclear atypia. Stratification was generally maintained and the cells were variously differentiated. High-grade lesions were characterized histologically by a very low nuclear/cytoplasmic ratio and a lack of stratification. Mitoses and abnormal mitoses might be found through the full thickness of the epithelium.
Statistieal analysis. The histologic diagnosis was regarded as the reference standard. High-grade squamous intraepithelial lesions were defined as the presence of disease. Low-grade lesions and the absence of dysplasia were defined as the absence of disease. The HPV test results of each patient were compared with the histologic diagnosis, and the sensitivity, specificity, predictive values, and 95% confidence intervals were determined.
A X 2 test was used to compare HPV test results and the prevalence of high-grade squamous intraepithelial lesions in patients with a single mildly or moderately dysplastic smear and those with repeated mildly or moderately dysplastic smears. A p value <0.05 was considered statistically significant. Table I .
Results

Study
The MY09/11 polymerase chain reaction plus SHARP Signal System was positive in 138 of the 190 patients (73%). Five of these 138 smears were positive with probe set A (3.6%), 117 with probe set B only (85%), and 16 with both sets A and B (12%). The oncogenic HPV types were detected by probe B as expected. Although set B contained probes for neither HPV-54 nor HPV-70, it was nevertheless able to detect both HPV types, apparently because of cross-hybridization with HPV type(s) present in mixture B.
Histologic study. The histologic diagnosis revealed no dysplasia in 24 patients, 110 low-grade squamous intraepithelial lesions, and 56 high-grade lesions. High-grade lesions were found in 28% of patients with a single mildly or moderately dysplastic smear and in 31% of paüents with a repeated mildly or inoderately dysplasüc smear (p = 0.62). 
Relationship between HPV detection and histologic diagnosis
CPI/IIG p@merase chain reaction. Of the 56 patients with a high-grade squamous intraepithelial lesion, 54 were found to be HPV positive by the CPI/]IG polymerase chain reaction, resulfing in a sensitivity of 96% (54/56) (Table II) . Of the 134 patients without highgrade squamous intraepithelial lesions, 44 were determined to be HPV negative, yielding a specificity of 33% (44/134) (Table II) . HPVtypes 16, 18, 31, 33, and 35 . When the detection of only HPV types 16, 18, 31, 33, and 35 by the CPI/IIG polymerase chain reaction was considered to be a positive test, the sensitivity was 68% (38/56) and the specificity was 70% (94/134) (Table II) .
MY09/ll polymerase &ain reaction plus SHARP Signal
System, The sensitivity of the SHARP Signal System was 95% (53/56) with both probe sets A and B. The sensitivity remained 95% (53/56) by use of probe B alone (Table II) . The specificity increased from 37% (49/134) when probe sets A and B were used to 40% (54/134) when probe B was used alone (Table II) .
CPI/HG polymerase chain reaction and MY09/ll polymerase chain reaction plus SHARP Signal System. The CPI/IIG
primer-mediated polymerase chain reaction was performed in those smears that were negative with SHARP probe B alone. When the results of these m,o tests were combined, 55 of the 56 high-grade squamous intraepithelial lesions were found to be positive, resulting in a sensitivity of 98% (55/56) and a specificity of 28% (38/134) (Table II) . The HPV test results were similar in pafients with a single mildly or moderately dysplastic smear and those with repeated mildly or moderately dysplastic smears.
Comment
Our findings indicate that it is feasible to use a negative HPV test result as a basis for selecting paaents who do not require colposcopy. The number of unnecessary colposcopms prevented by this secondm T triage has to be conrrasted with the number of pauents uäth an HPV-negative highgrade squamous intraepithelial lesion who would not have been refmTed for colposcopy. On the basis of a negative CPI/IIG test. colposcopy could have been avoided in 44 of the 134 patients (33%~ without high-grade lesions. The CPI/IIG test was negative in the cervical smears of toto patients with a high-grade lesion who would have heen missed Lg a negative CPI/IIG test had been used to rule out the need for colposcopy. When detection of only HPV types 16. 18, 31. 33. and 35 by the CPI/IIG polymerase chain reaction was instead used as a crlmrion, 94 of the 134 patients without high-grade lesions showed a negative test result, thereby increasing the speeificity of tesfing from 33% to 70%. However. this test cannot be recommended because 18 of 112 women with neganve test results proved to have high-grade lesions (Table III) . The same sensitixdty was achieved with the MY09/11 polymerase chain reaction plus SHA_RP Signal System with use of either both probe set A and B or probe set B only, whereas the specificity increased from 37% to 40% when probe B was used instead of probe A plus B. For out goal, probe A seems to be not us&ul. With probe B only, negative test results were obtained in 57 ùaanJ Obstet Gynecol (Table III) . The combined use of MY09/ll polymerase chain reaction plus SHARP Signal System with probe B only used and the CPI/IIG polymerase chain reaction would have avoided 39 (29%) unnecessary colposcopic examinations and missed only one patient ~dth a high-grade lesion ( Table III ) but requires that two separate tests have to be performed. So, both the MY09/ll polymerase chain reaction plus SHARP Signal System with probe B and the CPI/IIG polymerase chain reaction performed well in predicting patients without disease. The first test seems preferable because the SHARP assay is easy to perform and is available in standardized kits suitable for the use in nonresearch laboratories as well. In this respect, it is also worthwhile to further evaluate the performance of nonamplification assays, like the recently described microplate version of the Hybrid Capture method. 16 Mthough the identification and treatment of highgrade squamous intraepithelial lesions has been established as an effective strategy for reducing the incidence of cervical cancer, it has not been established that treating lesser grades of intraepithelial lesions will have an impact on cancer incidence. "%17 The majority of low-grade lesions will regress to normal or remain stable, with very few progressors. 2 Whether HPV detection can discriminate between progressive and nonprogressive low-grade lesions has to be assessed after follow-up of the padents in our study. Low-grade lesions without detectable HPV could appear to have a lower risk to progress compared with lesions with detectable HPV DNA even if no biopsies are taken. Remmink et al. 18 did not perform biopsies but considered the colposcopic impression as the diagnosis of the grade of dyplasia to study the natural history of cervical dysplasia. No progression was seen when no HPV or when low-risk HPV types were detected. The follow-up of patients with HPV-negative mildly or moderately dysplastic smears by repeat cytologic studies could therefore be a safe strategy, although the grade of dysplasia assessed by colposcopy alone 18 does not always correlate with the grade of dysplasia as assessed by histologic diagnosis. 19 The pretest probability, or prevalence, of the absence of high-grade squamous intraepithelial lesions was 71% and the posttest probability was 84% to 97%, depending on which HPV test was used. This means that HPV testing was able to increase the probability of identifying the absence of high-grade lesions before colposcopy by 13% to 26%. An improvement in the ability to predict highgrade lesions could also have important clinical implications. 6 In this study HPV testing afforded an additional 7% to 20% benefit, increasing the probability of highgrade lesions from 29% to 36% to 49%.
In our study population there was no significant difference in HPV test results or in the prevalence of high-grade squamous intraepithelial lesions between patients who had a single mildly or moderately dysplastic smear and those who had repeatedly mildly or moderately dysplastic smears. This observation does not favour the current recommendation in The Netherlands that a second mildly or moderately dysplastic smear is required before patients are referred for colposcopy.
We used the histologic diagnosis of the colposcopically directed biopsy specimens as a reference standard for the assessment of the HPV tests. However, the reliability of histologic diagnosis may be limited by sampling errors in the colposcopically directed biopsies. Indeed, several reports have shown a 20% to 50% disagreement between colposcopically directed biopsies and methods that allow the study of the whole transformation zone, such as large loop excision, cold-knife conization, and laser cone. 2°-22 Moreover, there is interobserver and intraobselwer variability in the histologic diagnosis, z3 Thus the relationship between HPV infection and histologic diagnosis not only depends on which HPV test is used but also may be influenced by errors in the histologic diagnosis.
HPV testing could be used in patients wirb smears read as mild or moderate dysplasia to avoid unnecessary " colposcopies, as was also suggested by Reid and Lorincz. 8 Moreover, HPV testing could also play a role in identifying candidates for colposcopy who might be missed by current cytologic screening techniques. Cuzick et aI. 24 reported high-grade squamous intraepithelial lesions in patients with HPV-positive cytologically normal srnears and in those with abnormal cytologic findings. This finding suggests that HPV testing could be important in
